Researcher profile

Mohamed S. Elmahdy

Mohamed S. Elmahdy contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 13 - UnverifiedVerification L1Unclaimed author
2works
0followers
2topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2020arXiv

A Cross-Stitch Architecture for Joint Registration and Segmentation in Adaptive Radiotherapy

Recently, joint registration and segmentation has been formulated in a deep learning setting, by the definition of joint loss functions. In this work, we investigate joining these tasks at the architectural level. We propose a registration network that integrates segmentation propagation between images, and a segmentation network to predict the segmentation directly. These networks are connected into a single joint architecture via so-called cross-stitch units, allowing information to be exchanged between the tasks in a learnable manner. The proposed method is evaluated in the context of adaptive image-guided radiotherapy, using daily prostate CT imaging. Two datasets from different institutes and manufacturers were involved in the study. The first dataset was used for training (12 patients) and validation (6 patients), while the second dataset was used as an independent test set (14 patients). In terms of mean surface distance, our approach achieved $1.06 \pm 0.3$ mm, $0.91 \pm 0.4$ mm, $1.27 \pm 0.4$ mm, and $1.76 \pm 0.8$ mm on the validation set and $1.82 \pm 2.4$ mm, $2.45 \pm 2.4$ mm, $2.45 \pm 5.0$ mm, and $2.57 \pm 2.3$ mm on the test set for the prostate, bladder, seminal vesicles, and rectum, respectively. The proposed multi-task network outperformed single-task networks, as well as a network only joined through the loss function, thus demonstrating the capability to leverage the individual strengths of the segmentation and registration tasks. The obtained performance as well as the inference speed make this a promising candidate for daily re-contouring in adaptive radiotherapy, potentially reducing treatment-related side effects and improving quality-of-life after treatment.

preprint2020arXiv

Patient-Specific Finetuning of Deep Learning Models for Adaptive Radiotherapy in Prostate CT

Contouring of the target volume and Organs-At-Risk (OARs) is a crucial step in radiotherapy treatment planning. In an adaptive radiotherapy setting, updated contours need to be generated based on daily imaging. In this work, we leverage personalized anatomical knowledge accumulated over the treatment sessions, to improve the segmentation accuracy of a pre-trained Convolution Neural Network (CNN), for a specific patient. We investigate a transfer learning approach, fine-tuning the baseline CNN model to a specific patient, based on imaging acquired in earlier treatment fractions. The baseline CNN model is trained on a prostate CT dataset from one hospital of 379 patients. This model is then fine-tuned and tested on an independent dataset of another hospital of 18 patients, each having 7 to 10 daily CT scans. For the prostate, seminal vesicles, bladder and rectum, the model fine-tuned on each specific patient achieved a Mean Surface Distance (MSD) of $1.64 \pm 0.43$ mm, $2.38 \pm 2.76$ mm, $2.30 \pm 0.96$ mm, and $1.24 \pm 0.89$ mm, respectively, which was significantly better than the baseline model. The proposed personalized model adaptation is therefore very promising for clinical implementation in the context of adaptive radiotherapy of prostate cancer.